Comments focus on concerns regarding the premature commercialization of cellular therapies and the implications of the BTC legislation for the oversight of Advanced Therapy Medicinal Products (ATMPs).
Read the comments.
Potential stem cell-derived therapies are advancing from the laboratory towards the clinic. These cell-based approaches present novel considerations for clinicians and the public alike. The ISSCR is dedicated to helping educate and inform clinicians, review boards, and the public with current, scientifically-grounded information on these advances and their application(s).
Guidelines that outline core principles of scientific rigor and research integrity, regularly updated based on scientific developments and disseminated to researchers, clinicians, organizations and institutions around the world.VIEW GUIDELINES